Antithrombotic and thrombolytic therapy for ischemic stroke.
Albers
G W
GW
Stanford University Medical Center, Stanford Stroke Center, Palo Alto, CA 94304-1705, USA.
Easton
J D
JD
Sacco
R L
RL
Teal
P
P
D000208:Acute Disease; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002545:Brain Ischemia / Q000188:drug therapy* / Q000517:prevention & control; D000075202:Contraindications; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000009:adverse effects
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D006493:Heparin; D001241:Aspirin